Glycemic control releases regenerative potential of pancreatic beta cells blocked by severe hyperglycemia.
嚴重高血糖阻礙胰島β細胞的再生潛力,而血糖控制有助釋放其再生潛力。
Cell Rep 2023-01-17
Glucagon Acting at the GLP-1 Receptor Contributes to β-Cell Regeneration Induced by Glucagon Receptor Antagonism in Diabetic Mice.
葡萄糖素作用於 GLP-1 受體有助於葡萄糖素受體拮抗劑誘導的糖尿病小鼠胰島β細胞再生。
Diabetes 2023-05-14
Gut microbiota-tryptophan metabolism-GLP-1 axis participates in β-cell regeneration induced by dapagliflozin.
腸道菌群-色氨酸代謝-GLP-1軸參與了dapagliflozin誘導的β細胞再生。
Diabetes 2024-03-12
GLP-1RA therapy increases circulating vascular regenerative cell contentin people living with type 2 diabetes.
GLP-1RA治療增加2型糖尿病患者循環中的血管再生細胞含量。
Am J Physiol Heart Circ Physiol 2024-06-14
Harmine and exendin-4 combination therapy safely expands human β cell mass in vivo in a mouse xenograft system.
Harmine和exendin-4組合療法在小鼠異種移植系統中安全擴大人類β細胞量。
Sci Transl Med 2024-07-10
Liraglutide enhances insulin secretion and prolongs the remission period in adults with newly diagnosed type 1 diabetes (the NewLira study): A randomized, double-blind, placebo-controlled trial.
Liraglutide 增強胰島素分泌並延長新診斷 1 型糖尿病成人的緩解期(NewLira 研究):一項隨機、雙盲、安慰劑對照試驗。
Diabetes Obes Metab 2024-08-28
Exploring a Synergistic Approach: Dual GLP-1 Agonist Combined with Degludec Basal Insulin for Early Type 1 Diabetes Treatment and its Impact on Albumin-Insulin Producing Cells Expression.
探索協同療法:雙重 GLP-1 激動劑結合 Degludec 基礎胰島素對早期 1 型糖尿病治療及其對白蛋白-胰島素產生細胞表達的影響。
Adv Pharm Bull 2024-08-29
Mechanistic Pathways and Clinical Implications of GLP-1 Receptor Agonists in Type 1 Diabetes Management.
GLP-1 受體激動劑在 1 型糖尿病管理中的機制途徑及臨床意義。
Int J Mol Sci 2024-09-14